Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: Prospective nonrandomized trial on 125 patients

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1549-1552

  Santander, C ^a   Gravalos R G ^a   Gomez Cedenilla A ^a   Cantero, J ^a   Pajares, J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT PEPTIC ULCER; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RANITIDINE; RECURRENCE; STOMACH ULCER; TIME FACTORS;

EID: 0029760573     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Freston JW. H2-receptor antagonists and duodenal ulcer recurrence: Analysis of efficacy and commentary on safety costs and patient selection. Am J Gastroenterol 1987;82:1242-1249.
2. Walan A, Bianchi Porro G, Hentschel E, et al. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987;22:397-405.
3. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;2:1311-4.
4. Smith AC, Price AB, Borriello P, et al. A comparison of ranitidine and tripotassium dicitratro bismuthate (TDB) in relapse rate of duodenal ulcer. The role of Campylobacter pylori. Gastroenterology 1988;94:43.
5. O'Riordan T, Mathai E, Tobin A, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 999-1002.
6. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
7. Lambert JR, Borromeo M, Korman KO, et al. Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers: Role of Campylobacter pyloridis. Gastroenterology 1987;92:1489 (abstract).
8. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331:717-27.
9. Peterson WL. Prevention of upper gastrointestinal bleeding. N Engl J Med 1994;330:428-9 (editorial).
10. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric orduodenal ulcer: A randomized, controlled study. Ann Intern Med 1992;116:705-8.
11. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
12. Penston JG, Wormsley KG. Nine years maintenance treatment with ranitidine for patients with duodenal ulcer. Aliment Pharmacol Ther 1992;6:629-46.
13. Boles RS, Cassidy WJ, Jordan SM. Medical versus surgical management for the complication of hemorrhage in duodenal ulcer. Gastroenterology 1957;32:52.
14. Donddson RM, Handy J, Papper S. Five-year follow-up study of patients with bleeding duodenal ulcer with or without surgery. N Engl J Med 1958;259:201.
15. Borland JL, Hancock WR, Borland JL. Recurrent upper gastrointestinal hemorrhage in peptic ulcer. Gastroenterology 1967;52:631-637.
16. Jensen DM, Cheng S, Kovacs TOG, et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994;330:382-6.
17. Penston JG, Wormsley KG. Efficacy and safety of long term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989;24: 1145-52.
18. Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection. Problems and pitfalls. Am J Gastroenterol 1990;1545-51.
19. Patchett S, Beattie S, Leen E, et al. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992;87:24-7.
20. Graham DY, Hepps KS, Ramírez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
21. Maier M, Schilling D, Dorlars D, et al. Eradication of Helicobacter pylori or H2 blocker maintenance therapy after peptic ulcer bleeding: A prospective randomized trial. Gastroenterology 1995;108(suppl): A156 (abstract).
22. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
23. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.